BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/27/2026 7:05:41 AM | Browse: 3 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 119668
Country South Korea
Category Gastroenterology & Hepatology
Manuscript Type Clinical Trials Study
Article Title Efficacy of 7-day and 14-day potassium-competitive acid blocker-based bismuth-containing quadruple regimen for Helicobacter pylori infection
Manuscript Source Unsolicited Manuscript
All Author List Chang Kyo Oh, Hyun Lim, Jin Hee Noh, Eun Jeong Gong, Seung In Seo, Chang Seok Bang, Yu Jin Kim, Woon Geon Shin, Jin Bae Kim, Hyun Joo Jang and Gwang Ho Baik
Funding Agency and Grant Number
Funding Agency Grant Number
HK inno.N, Republic of Korea No. KCAB_017
Corresponding Author Hyun Lim, MD, PhD, Department of Gastroenterology, Hallym University College of Medicine, Hallym University Sacred Heart Hospital, 22 Gwanpyeong-Ro 170-Gil, Dongan-Gu, Anyang 14068, South Korea. hlim77@hallym.or.kr
Key Words Helicobacter pylori; Potassium-competitive acid blockers; Proton pump inhibitors; Bismuth-containing quadruple therapy; Bismuth-metronidazole; Tetracycline
Core Tip Bismuth-containing quadruple therapy is recommended as first-line treatment for Helicobacter pylori in regions with high clarithromycin resistance, yet the optimal acid suppressant and treatment duration remain unclear. This multicenter randomized trial is the study to evaluate tegoprazan, a potassium-competitive acid blocker, within a bismuth-metronidazole-tetracycline quadruple regimen. The 14-day tegoprazan-based regimen achieved non-inferior eradication compared with the conventional 14-day proton pump inhibitor-based regimen, whereas the 7-day regimen did not. These results highlight that tegoprazan-based bismuth quadruple therapy requires a 14-day duration to ensure adequate eradication efficacy.
Citation Oh CK, Lim H, Noh JH, Gong EJ, Seo SI, Bang CS, Kim YJ, Shin WG, Kim JB, Jang HJ, Baik GH. Efficacy of 7-day and 14-day potassium-competitive acid blocker-based bismuth-containing quadruple regimen for Helicobacter pylori infection. World J Gastroenterol 2026; In press
Received
2026-02-03 01:56
Peer-Review Started
2026-02-03 01:57
First Decision by Editorial Office Director
2026-03-04 09:09
Return for Revision
2026-03-04 09:09
Revised
2026-03-17 02:06
Publication Fee Transferred
2026-03-25 10:14
Second Decision by Editor
2026-05-27 02:42
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-05-27 07:05
Articles in Press
2026-05-27 07:05
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com